Open Nav

FenoLogica Biosciences, Inc.

  • Sean MacLeod, FenoLogica Biosciences

Fundraising, Strategic Partnering, Market Awareness

  • Date:Wednesday, October 17
  • Time:2:45 PM - 3:00 PM
  • Room:Elizabethan D
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Unlocking Opportunities in the New Frontier of Synthetic Biology - FenoLogica enables microbial researchers and bioengineers to do what they haven't been able to before. Our powerful instrumentation and cloud-based software tools are specifically designed to unlock the vital link between genomics and the understanding of biologic traits and behaviors (phenotypes) in cell biology. Functional data from large, synthetically derived, gene-variant cell libraries – using dynamic multiplexed assays – lead to broader experimental inquiry, quicker discoveries, and more precise biologic signatures. This data is critical to advancing everything from genetic related diagnostics and pharmaceutical discovery, to the development of novel biofuels, agriculture, food science and biomaterials. These techniques have promise in solving the cause and cure of disease, helping our planet’s sustainability, and advancing humankind.
  • Company
  • Company HQ City:Seattle
  • Company HQ Country:United States
  • Company HQ State:Washington‚ State 
  • CEO/Top Company Official:Sean M. MacLeod, MBA
  • Year Founded:2016
  • Main Therapeutic Focus:Tools/Drug Development Support Tech
  • Lead Product in Development :Maverick High-throughput Phenotype Classification Platform
  • Development Phase of Primary Product:Discovery
  • Total Amount Raised to Date, In All Rounds:655,000.00
Sean MacLeod
FenoLogica Biosciences